Market revenue in 2024 | USD 31.9 million |
Market revenue in 2030 | USD 77.2 million |
Growth rate | 16.4% (CAGR from 2025 to 2030) |
Largest segment | Proteomic testing |
Fastest growing segment | Metabolomic Testing |
Historical data covered | 2018 - 2023 |
Base year for estimation | 2024 |
Forecast period covered | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Proteomic Testing, Metabolomic Testing, Genomic Testing |
Key market players worldwide | Abbott Laboratories, Danaher Corp, Siemens Healthineers AG ADR, Roche, QuidelOrtho Corp, BioMerieux SA, Trinity Biotech PLC ADR, Abaxis |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to heart failure poc & loc devices market will help companies and investors design strategic landscapes.
Proteomic testing was the largest segment with a revenue share of 57.68% in 2024. Horizon Databook has segmented the Europe heart failure poc & loc devices market based on proteomic testing, metabolomic testing, genomic testing covering the revenue growth of each sub-segment from 2018 to 2030.
Adoption of POC testing in hospital settings is continuously increasing across European countries. However, its usage is not high as in the U.S. A number of efforts by key stakeholders in the market to drive adoption of POC & LOC devices in the region are anticipated to boost revenue growth.
In June 2019, a conference titled “Point-of-Care, Biosensors & Mobile Diagnostics Europe 2019” was hosted by the Netherlands. This annual conference involved a discussion about the expanding POC tests and wearables, including microfluidics-based and LOC approaches, from innovative technologies to regulatory approval.
Furthermore, the European Society of Cardiology (ESC), involved in improving management of acute and chronic heart failure, is one of the key contributors in the Europe market. In 2016, ESC published guidelines regarding the diagnosis and treatment of chronic and acute heart failure in the region.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe heart failure poc & loc devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe heart failure poc & loc devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account